SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-019667
Filing Date
2018-03-14
Accepted
2018-03-14 18:13:29
Documents
1
Period of Report
2018-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4287
  Complete submission text file 0001209191-18-019667.txt   5800
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DIRVE, SUITE 600 SAN DIEGO CA 92130
Business Address
Hall William Walmsley (Reporting) CIK: 0001726731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36754 | Film No.: 18690563